GUANZE MEDICAL Reports Fiscal 2025 Loss Attributable to Shareholders of RMB29.72 Million

Stock News
03/31

GUANZE MEDICAL (02427) announced its annual results for the period ending December 31, 2025. Revenue amounted to RMB88.45 million, representing a decrease of 43.2% compared to the previous year. The loss attributable to the company's owners was RMB29.72 million, a significant shift from a profit of RMB17.20 million in the same period last year. The basic loss per share was RMB0.03. The decline in total annual revenue was primarily due to reduced sales of medical imaging film products and medical imaging cloud services.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10